UBS O'Connor’s Medicines Co MDCO Stock Holding History

UBS O'Connor’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-966,509	Closed	-$82.1M	–	442
2019 Q4	$82.1M	Buy	+966,509	New	+$64.5M	2.32%	8

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

UBS O'Connor's MDCO Position: Q1 2020 in Review

UBS O'Connor sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 966,509 shares — an estimated $82.1M sold.

UBS O'Connor first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $82.1M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

UBS O'Connor reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
UBS O'Connor sold 966,509 Medicines Co shares in Q1 2020, an estimated $82.1M.
UBS O'Connor first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
UBS O'Connor's Medicines Co position peaked at $82.1M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on UBS O'Connor's 13F filing for Q1 2020, filed 15 May 2020.